rs147157374
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_006005.3(WFS1):c.1079G>A(p.Cys360Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C360R) has been classified as Uncertain significance.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.1079G>A | p.Cys360Tyr | missense_variant | 8/8 | ENST00000226760.5 | |
WFS1 | NM_001145853.1 | c.1079G>A | p.Cys360Tyr | missense_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WFS1 | ENST00000226760.5 | c.1079G>A | p.Cys360Tyr | missense_variant | 8/8 | 1 | NM_006005.3 | P2 | |
ENST00000661896.1 | n.1337+3041C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251418Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135888
GnomAD4 exome AF: 0.000197 AC: 288AN: 1461888Hom.: 0 Cov.: 100 AF XY: 0.000193 AC XY: 140AN XY: 727246
GnomAD4 genome AF: 0.000263 AC: 40AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74276
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 22, 2024 | Reported as a variant of uncertain significance in a patient referred for whole exome sequencing who was also compound heterozygous for another variant of uncertain significance in WFS1 (PMID: 27959697); patient clinical information not provided; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26435059, 31264968, 27959697) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 06, 2022 | PP3, PM2_supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 360 of the WFS1 protein (p.Cys360Tyr). This variant is present in population databases (rs147157374, gnomAD 0.02%). This missense change has been observed in individual(s) with multiple congenital anomalies or with type 1 diabetes (PMID: 27959697, 31264968). ClinVar contains an entry for this variant (Variation ID: 374398). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WFS1 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Type 2 diabetes mellitus;C1833021:Autosomal dominant nonsyndromic hearing loss 6;C3280358:Wolfram-like syndrome;C3805412:Cataract 41;C4551693:Wolfram syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Wolfram syndrome 1 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Baylor Genetics | Sep 24, 2014 | Our laboratory reported dual molecular diagnoses in ACTG1 (NM_001199954.1, c.118C>T) and WFS1 (NM_001145853.1, c.2191A>G and c.1079G>A in trans) in one individual with reported features of delayed motor milestones, delayed speech, mild intellectual disability, congenital bilateral sensorineural hearing loss, dysmorphic features and eye anomalies (strabismus, possible cortical visual impairment). Brain MRI showed dysplastic corpus callosum and possible intracranial lipoma. Additionally, this variant was seen once in our laboratory in trans with another missense variant (c.2452C>T) in a 22-year-old male with muscle weakness, obesity and type II diabetes, hypertension, fatigue and fibromyalgia, primary hypothyroidism, thymic hyperplasia, short stature, and nonalcoholic steatohepatitis - |
Autosomal dominant nonsyndromic hearing loss 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at